£20.22
1.84% today
London, Dec 04, 01:48 pm CET
ISIN
GB00B2425G68
Symbol
CRW

Craneware Stock price

£20.60
-1.71 7.65% 1M
-0.42 1.98% 6M
-0.17 0.80% YTD
-2.53 10.93% 1Y
-0.37 1.75% 3Y
-1.03 4.77% 5Y
+13.60 194.18% 10Y
+19.56 1,871.67% 20Y
London, Closing price Wed, Dec 03 2025
-0.50 2.37%
ISIN
GB00B2425G68
Symbol
CRW

Key metrics

Basic
Market capitalization
£741.6m
Enterprise Value
£717.4m
Net debt
positive
Cash
£55.9m
Shares outstanding
35.4m
Valuation (TTM | estimate)
P/E
37.5 | 16.9
P/S
3.6 | 3.2
EV/Sales
3.5 | 3.1
EV/FCF
16.1
P/B
2.2
Dividends
DPS
£0.30
Yield 1Y | 5Y
1.4% | 1.5%
Growth 1Y | 5Y
1.7% | 2.2%
Payout 1Y | 3Y
53.6% | 75.9%
Increased
2 Years
Financials (TTM | estimate)
Revenue
£205.7m | £229.5m
EBITDA
£61.9m | £72.8m
EBIT
£27.7m | £56.2m
Net Income
£19.7m | £43.3m
Free Cash Flow
£44.5m
Growth (TTM | estimate)
Revenue
8.7% | 11.6%
EBITDA
12.7% | 17.7%
EBIT
28.6% | 103.2%
Net Income
68.0% | 120.1%
Free Cash Flow
78.8%
Margin (TTM | estimate)
Gross
87.2%
EBITDA
30.1% | 31.7%
EBIT
13.5%
Net
9.6% | 18.9%
Free Cash Flow
21.7%
Financial Health
Equity Ratio
61.3%
Return on Equity
5.8%
ROCE
7.5%
ROIC
6.8%
Debt/Equity
0.1
More
EPS
£0.6
FCF per Share
£1.3
Short interest
-
Employees
747
Rev per Employee
£280.0k
Show more

Is Craneware a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Craneware Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Craneware forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Craneware forecast:

Buy
92%
Hold
8%

Financial data from Craneware

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
206 206
9% 9%
100%
- Direct Costs 26 26
3% 3%
13%
179 179
11% 11%
87%
- Selling and Administrative Expenses 5.70 5.70
27% 27%
3%
- Research and Development Expense - -
-
-
62 62
13% 13%
30%
- Depreciation and Amortization 34 34
2% 2%
17%
EBIT (Operating Income) EBIT 28 28
29% 29%
13%
Net Profit 20 20
68% 68%
10%

In millions GBP.

Don't miss a Thing! We will send you all news about Craneware directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Craneware Plc engages in the provision of software and support services for the healthcare industry. The Company’s Trisus cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. The company combines revenue integrity, cost management, 340B performance, and decision enablement into a single software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others. The company also offers Trisus Decision Support, Trisus Labor Productivity, Trisus Pricing Integrity Suite, and others.

Head office United Kingdom
Employees 747
Website www.thecranewaregroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today